세계의 혈전증 치료제 시장 2019-2023

■ 영문 제목 : Global Thrombosis Drugs Market 2019-2023

Technavio가 발행한 조사보고서이며, 코드는 IRTNTR30379 입니다.■ 상품코드 : IRTNTR30379
■ 조사/발행회사 : Technavio
■ 발행일 : 2018년 11월 28일
■ 페이지수 : 109
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 글로벌, 미주, 유럽, 아시아
■ 산업 분야 : 의료
■ 판매가격 / 옵션 (부가세별도)
Single User (1명 열람용)USD2,500 ⇒환산₩2,875,000견적의뢰/주문/질문
Five User (5명 열람용)USD3,000 ⇒환산₩3,450,000견적의뢰/주문/질문
Enterprise License (전사내 공유가능)USD4,000 ⇒환산₩4,600,000견적의뢰/구입/질문
가격옵션 설명
- 지불하실 금액은 상기 원화금액에 부가세(10%)를 더한 금액입니다.
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제이며, 납품후 5일이내에 청구서를 발행/송부합니다.
본 조사보고서는 혈전증 치료제의 세계시장에 대해서 조사분석한 자료로서, 혈전증 치료제의 세계시장규모, 시장동향, 시장환경 분석, 세그멘트별 분석, 지역별 분석 (미주, 유럽, 아시아), 관련기업 정보등이 포함되어 있습니다.
■ 보고서 개요

About this marketSedentary lifestyle is resulting in an increase in the number of thrombosis cases. The increase in sedentary lifestyle is leading to the rise in the prevalence of obesity across the world, thus increasing the risk of thrombosis. Technavio’s analysts have predicted that the thrombosis drugs market will register a CAGR of more than 9% by 2023.
Market Overview
Growing awareness of cardiac care
The increasing awareness of cardiac care is leading to the early diagnosis of various cardiac diseases. Various awareness camps have been organized by the governments and non-government organizations across the world to increase the awareness of heart health among the population.
Strong side-effects of anticoagulants
Anticoagulants or blood thinners are medications that are developed to dissolve blood clots in the body. Blood thinners have high efficacy. However, the side effects associated with the use of these drugs to treat thrombosis are high.
For the detailed list of factors that will drive and challenge the growth of the thrombosis drugs market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be concentrated and with the presence of several companies including Johnson & Johnson, and Sanofi the competitive environment is quite intense. Factors such as the increase in sedentary lifestyle and the increasing awareness of cardiac care, will provide considerable growth opportunities to thrombosis drugs manufactures. Boehringer Ingelheim, Bristol-Myers Squibb, DAIICHI SANKYO, Johnson & Johnson, and Sanofi are some of the major companies covered in this report.

‘With the presence of a considerable number of companies, this market appears to be concentrated and with all companies constantly focusing improving their market positions, the competitive environment among the players is quite intense. The market is witnessing the entry of various generic drug manufacturing companies that are coming up with generic versions of the drugs.’

■ 보고서 목차

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: PIPELINE
PART 07: MARKET SEGMENTATION BY INDICATION
• Market segmentation by indication
• Comparison by indication
• Pulmonary embolism – Market size and forecast 2018-2023
• DVT – Market size and forecast 2018-2023
• Market opportunity by indication
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• Americas – Market size and forecast 2018-2023
• EMEA – Market size and forecast 2018-2023
• APAC – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Boehringer Ingelheim
• Bristol-Myers Squibb
• DAIICHI SANKYO
• Johnson & Johnson
• Sanofi
PART 14: APPENDIX
• Research methodology
• List of abbreviations
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Years in consideration
Exhibit 02: Global hematology drugs market
Exhibit 03: Segments of global hematology drugs market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Global thrombosis drugs market pipeline: Overview
Exhibit 19: Indication – Market share 2018-2023 (%)
Exhibit 20: Comparison by indication
Exhibit 21: Pulmonary embolism – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Pulmonary embolism – Year-over-year growth 2019-2023 (%)
Exhibit 23: DVT – Market size and forecast 2018-2023 ($ millions)
Exhibit 24: DVT – Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by indication
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: Americas – Market size and forecast 2018-2023 ($ millions)
Exhibit 30: Americas – Year-over-year growth 2019-2023 (%)
Exhibit 31: EMEA – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: EMEA – Year-over-year growth 2019-2023 (%)
Exhibit 33: APAC – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: APAC – Year-over-year growth 2019-2023 (%)
Exhibit 35: Key leading countries
Exhibit 36: Market opportunity
Exhibit 37: Decision framework
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Boehringer Ingelheim – Vendor overview
Exhibit 45: Boehringer Ingelheim – Business segments
Exhibit 46: Boehringer Ingelheim – Organizational developments
Exhibit 47: Boehringer Ingelheim – Geographic focus
Exhibit 48: Boehringer Ingelheim – Segment focus
Exhibit 49: Boehringer Ingelheim – Key offerings
Exhibit 50: Boehringer Ingelheim – Key customers
Exhibit 51: Bristol-Myers Squibb – Vendor overview
Exhibit 52: Bristol-Myers Squibb – Business segments
Exhibit 53: Bristol-Myers Squibb – Organizational developments
Exhibit 54: Bristol-Myers Squibb – Geographic focus
Exhibit 55: Bristol-Myers Squibb – Key offerings
Exhibit 56: Bristol-Myers Squibb – Key customers
Exhibit 57: DAIICHI SANKYO – Vendor overview
Exhibit 58: DAIICHI SANKYO – Business segments
Exhibit 59: DAIICHI SANKYO – Organizational developments
Exhibit 60: DAIICHI SANKYO – Geographic focus
Exhibit 61: DAIICHI SANKYO – Key offerings
Exhibit 62: DAIICHI SANKYO – Key customers
Exhibit 63: Johnson & Johnson – Vendor overview
Exhibit 64: Johnson & Johnson – Business segments
Exhibit 65: Johnson & Johnson – Organizational developments
Exhibit 66: Johnson & Johnson – Geographic focus
Exhibit 67: Johnson & Johnson – Segment focus
Exhibit 68: Johnson & Johnson – Key offerings
Exhibit 69: Johnson & Johnson – Key customers
Exhibit 70: Sanofi – Vendor overview
Exhibit 71: Sanofi – Business segments
Exhibit 72: Sanofi – Organizational developments
Exhibit 73: Sanofi – Geographic focus
Exhibit 74: Sanofi – Segment focus
Exhibit 75: Sanofi – Key offerings
Exhibit 76: Sanofi – Key customers
Exhibit 77: Validation techniques employed for market sizing
Exhibit 78: List of abbreviations



■ 기재된 기업 리스트

Boehringer Ingelheim, Bristol-Myers Squibb, DAIICHI SANKYO, Johnson & Johnson, Sanofi


■ 조사 방법

1차조사 (업계 전문가, 기업, 대리점, 고객에 대한 심층 인터뷰를 포함), 2차조사 (Technavio 플랫폼, 산업자료, 기업 보고서, 뉴스 기사, 애널리스트 레포트, 무역협회, 정부발행 자료 등)

※본 조사보고서 [세계의 혈전증 치료제 시장 2019-2023] (코드 : IRTNTR30379) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 혈전증 치료제 시장 2019-2023] 에 대해서 E메일 문의는 여기를 클릭하세요.